Isabel has been a member of the Atrys Health team since 2007, when she was appointed CEO. She holds a degree in Law and a Master's degree in Marketing Management. She has extensive experience in the management of biotechnology and oncology companies at national and international level. Before joining Atrys, she spent eight years as CEO of PharmaMar (a biopharmaceutical R&D&I company) and five years as CFO of the Zeltia Group. 

She began her career in management positions in several venture capital companies and in the Audit division of Arthur Andersen. She joined ATRYS in 2007 and was appointed CEO that same year.